Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADDLE: Dolutegravir-Lamivudine in Naive HIV
NCT02211482Phase 4Completed
- Sponsor
- Fundación Huésped
- Start
- Oct 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir, lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Fundación Huésped. Started Oct 2014; status: completed.
02
Drugs
dolutegravirlamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02211482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211482.